↓ Skip to main content

Blood-brain barrier impairment in MPS III patients

Overview of attention for article published in BMC Neurology, November 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
37 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Blood-brain barrier impairment in MPS III patients
Published in
BMC Neurology, November 2013
DOI 10.1186/1471-2377-13-174
Pubmed ID
Authors

Svitlana Garbuzova-Davis, Santhia Mirtyl, Sebastian A Sallot, Diana G Hernandez-Ontiveros, Edward Haller, Paul R Sanberg

Abstract

Mucopolysaccharidosis type III (MPS III) is an autosomal recessive disorder caused by deficiency of a specific enzyme leading to heparan sulfate (HS) accumulation within cells and to eventual progressive cerebral and systemic organ abnormalities. Different enzyme deficiencies comprise the MPS III subcategories (A, B, C, D). Since neuropathological manifestations are common to all MPS III types, determining blood-brain barrier (BBB) condition may be critical to understand potential additional disease mechanisms.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 32%
Student > Ph. D. Student 9 24%
Student > Bachelor 5 14%
Student > Master 2 5%
Other 2 5%
Other 5 14%
Unknown 2 5%
Readers by discipline Count As %
Agricultural and Biological Sciences 10 27%
Medicine and Dentistry 7 19%
Biochemistry, Genetics and Molecular Biology 7 19%
Neuroscience 5 14%
Business, Management and Accounting 1 3%
Other 3 8%
Unknown 4 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 November 2013.
All research outputs
#3,079,571
of 4,507,144 outputs
Outputs from BMC Neurology
#653
of 900 outputs
Outputs of similar age
#69,492
of 102,745 outputs
Outputs of similar age from BMC Neurology
#57
of 80 outputs
Altmetric has tracked 4,507,144 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 900 research outputs from this source. They receive a mean Attention Score of 3.3. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 102,745 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.